Clinical Trials
3 trialsNCT05332210 2026-04-28
Evaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized Myasthenia Gravis
Harbour BioMed (Guangzhou) Co. Ltd.
Phase 3 Completed
NCT04346888 2023-03-08
A Study to Evaluate the Efficacy, Safety and PD and PK of HBM9161 in MG Patients
Harbour BioMed (Guangzhou) Co. Ltd.
Phase 2 Completed
NCT05039190 2023-03-08
MG
Harbour BioMed (Guangzhou) Co. Ltd.
Phase 3 Completed